"10.1371_journal.pone.0129546","plos one","2015-06-09T00:00:00Z","Jeremy C Parker; Isobel Douglas; Jennifer Bell; David Comer; Keith Bailie; Grzegorz Skibinski; Liam G Heaney; Michael D Shields","Centre for Infection and Immunity, Health Sciences Building, Queenâ€™s University Belfast, Belfast, Northern Ireland; Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland","Conceived and designed the experiments: JCP GS LGH MDS. Performed the experiments: JCP JB DC. Analyzed the data: JCP MDS. Wrote the paper: JCP LGH MDS. Obtained clinical samples for the study: ID KB.","Prof. Heaney has received grants and has grants pending outside of the submitted work including funding from GlaxoSmithKline ($30,000 â€ unrestricted research grant to support the British Thoracic Society Severe Asthma Network and National Registry, $150,000 â€ support programme for Regional Difficult Asthma Service, $144,000 â€ unrestricted research grant â€ Cost of Refractory Asthma in the UK â€ an economic analysis), Medimmune ($75,000 â€ unrestricted research grant to support the British Thoracic Society Severe Asthma Network and National Registry), Novartis UK ($48,000 - unrestricted research grant to support the British Thoracic Society Severe Asthma Network and National Registry), AstraZeneca ($90,0000 - unrestricted research grant to support the British Thoracic Society Severe Asthma Network and National Registry), Genentech Inc ($15,000 â€ bronchial biopsy study, $150,000 â€ biomarker study, $36,000 support with Department of Education and Learning Northern Ireland (DEL/CAST scheme) or a PhD studentship), Medical Research Council UK (Â£409,462 â€ laboratory based study), Northern Ireland Chest Heart and Stroke Association (Â£90,281 â€ biomarker study), Hoffman la Roche UK (Â£650,000 â€ development of clinical trial and support for National Registry), Asthma UK/Northern Ireland Chest Heart and Stroke Association (Â£166,282 â€ post-doctoral Fellowship funding and laboratory consumables). Additionally, Prof. Heaney has also received payment for lectures including service on speakers bureaus from the Pharmaceutical Industry (GlaxoSmithKline, Merck, Sharpe & Dohme, Nycomed, Novartis, Genentech Inc and Astra Zeneca) totalling approximately $60,000 in the past 5 years. Prof. Heaney has also received support to attend the American Thoracic Society and European Respiratory Society Annual Meetings in the past 3 years from Astra Zeneca, Chiesi, Novartis, and GlaxoSmithKline. Prof. Shields has received personal fees outside of the submitted work including funding from GlaxoSmithKline and Novartis for lectures on childhood asthma/cough at educational events and support to attend the annual European Respiratory Society meeting.","2015","06","Jeremy C Parker","JCP",8,TRUE,4,3,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
